home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies
Circle Pharma Closes $90 Million Series D Financing to Advance Innovative Oral Macrocycle Therapies
Post navigation
Previous Post
Previous
Circle Pharma announces preclinical data poster presentation of CID-078, a first-and-only-in-class Cyclin A/B RxL inhibitor at the 2024 World Conference on Lung Cancer
Next Post
Next
Alumis to Participate in Upcoming September Investor Conferences